Although some candidate markers, such as Rab1, Rab18, and Ezrin which are elevated in HCC, were reported to promote HCC progression [26–29], the oncogenic or tumor-suppressive roles of other candidate proteins we found in HCC tissues remain unclear. This evidence concerns the gene RAB18 and hepatocellular carcinoma.